63 related articles for article (PubMed ID: 27666548)
1. [Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer].
Peng Y; Wang Y; Li J; Hao X; Hu X
Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):590-4. PubMed ID: 27666548
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission.
Muley T; Herth FJ; Heussel CP; Kriegsmann M; Thomas M; Meister M; Schneider MA; Wehnl B; Mang A; Holdenrieder S
Tumour Biol; 2024; 46(s1):S219-S232. PubMed ID: 37840518
[TBL] [Abstract][Full Text] [Related]
3. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
Trulson I; Klawonn F; von Pawel J; Holdenrieder S
Tumour Biol; 2024; 46(s1):S81-S98. PubMed ID: 38277317
[TBL] [Abstract][Full Text] [Related]
4. Lack of clinical utility of serum macrophage migration inhibitory factor (MIF) for monitoring therapy response and estimating prognosis in advanced lung cancer.
Rupp A; Bahlmann S; Trimpop N; von Pawel J; Holdenrieder S
Tumour Biol; 2024; 46(s1):S341-S353. PubMed ID: 37545291
[TBL] [Abstract][Full Text] [Related]
5. A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.
Yu Z; Lu H; Si H; Liu S; Li X; Gao C; Cui L; Li C; Yang X; Yao X
PLoS One; 2015; 10(5):e0125517. PubMed ID: 25996920
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the Efficacy of Irinotecan in the Second-line Treatment of Refractory and Relapsed Small Cell Lung Cancer].
Xing H; Zhang J; Ge F; Yu X; Bian H; Zhang F; Fang J
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):167-172. PubMed ID: 33819966
[TBL] [Abstract][Full Text] [Related]
7. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
Miao Q; Lv X; Luo L; Zhang J; Cai B
Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of body mass index and serum albumin as the indicators of nutritional status in small cell lung cancer.
Tas F; Ozturk A; Erturk K
Postgrad Med; 2024 Mar; 136(2):208-217. PubMed ID: 38456321
[TBL] [Abstract][Full Text] [Related]
9. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.
Wu L; Chen X; Peng T; Tang E; Bai W; Chen L
Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of PD-1/PD-L1 Inhibitor and Chemotherapy in Treatment of Advanced Small Cell Lung Cancer.
Tian W; Zhao J; Wang W; Li Y
Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37971453
[TBL] [Abstract][Full Text] [Related]
11. Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer.
Zhang X; Qin Y; Chen X; Xiong M; Shu S
Technol Cancer Res Treat; 2024; 23():15330338241240683. PubMed ID: 38613340
[No Abstract] [Full Text] [Related]
12. Neither the presence nor the severity of hyponatremia affected the outcome of the patients with small cell lung cancer.
Tas F; Ozturk A; Erturk K
Ir J Med Sci; 2023 Aug; 192(4):1613-1619. PubMed ID: 36279041
[TBL] [Abstract][Full Text] [Related]
13. Serum hyaluronic acid and procollagen III, N-terminal propeptide levels are highly associated with disease severity and predict the progression of COVID-19.
Yang T; Liu LL; Wu XH; Xue JG; He CY
Front Cell Infect Microbiol; 2023; 13():1249038. PubMed ID: 37860066
[TBL] [Abstract][Full Text] [Related]
14. Correction of the NSE concentration in hemolyzed serum samples improves its diagnostic accuracy in small-cell lung cancer.
Genet SAAM; Visser E; van den Borne BEEM; Soud MY; Belderbos HNA; Stege G; de Saegher MEA; Eduati F; Broeren MAC; van Dongen J; Brunsveld L; van de Kerkhof D; Scharnhorst V
Oncotarget; 2020 Jul; 11(27):2660-2668. PubMed ID: 32676167
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of neuron-specific enolase as a prognostic factor for disease progression in patients with GET/NEN in the pancreas and the small intestine.
Fuksiewicz M; Kowalska M; Kolasinska-Cwikla A; Kotowicz B
Endocr Connect; 2022 Sep; 11(9):. PubMed ID: 35900770
[TBL] [Abstract][Full Text] [Related]
16. The Usefulness of the Ratio of Antigen-Autoantibody Immune Complexes to Their Free Antigens in the Diagnosis of Non-Small Cell Lung Cancer.
Kim H; Lee JK; Oh AC; Kim HR; Hong YJ
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761366
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin-secreting neuroendocrine tumor of the larynx, a diagnostic challenge of a rare neoplasm: a case report and literature review.
Filippini DM; Abeshi A; Tober N; Marchese PV; Andrini E; Lamberti G; Agosti R; Molinari G; Fermi M; Presutti L
AME Case Rep; 2024; 8():21. PubMed ID: 38234336
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China.
Wu XY; Hu YB; Li HJ; Wan B; Zhang CX; Zhang B; Hu H; Zhang Q; Lv TF; Zhan P; Song Y
J Cell Mol Med; 2018 Sep; 22(9):4328-4334. PubMed ID: 29989303
[TBL] [Abstract][Full Text] [Related]
19. Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.
Wojcik E; Kulpa JK
Lung Cancer (Auckl); 2017; 8():231-240. PubMed ID: 29238236
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of ProGRP for small cell lung cancer in different stages.
Dong A; Zhang J; Chen X; Ren X; Zhang X
J Thorac Dis; 2019 Apr; 11(4):1182-1189. PubMed ID: 31179060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
